Solid Tumor Ablation Platform
Early-stage solid tumors
Pre-clinicalActive
Key Facts
About Current Surgical
Current Surgical is a private, pre-revenue medical device startup founded in 2016, building a foundational platform for the next generation of minimally invasive, digital surgery. Its core technology integrates AI-processed real-time imaging with precision focused ultrasound ablation in a closed-loop control system, initially targeting early-stage solid tumor ablation. The company has a clear multi-year pipeline to expand into cardiac, pain, and neurological markets, is backed by elite investors like True Ventures, and has secured non-dilutive funding from the NIH and NSF to advance its platform.
View full company profile